Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018204386) FORMULATIONS AND COMPOSITIONS OF DOCETAXEL
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/204386 International Application No.: PCT/US2018/030489
Publication Date: 08.11.2018 International Filing Date: 01.05.2018
IPC:
A61K 31/337 (2006.01) ,A61K 38/17 (2006.01) ,A61K 38/38 (2006.01) ,A61K 47/42 (2017.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
337
having four-membered rings, e.g. taxol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
38
Albumins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
42
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof
Applicants:
SUN, Qun [US/US]; US
ZHUHAI BEIHAI BIOTECH CO., LTD. [CN/CN]; 3F, Blg 2, No.6366 Zhuhai Ave. Jinwan Zhuhai, CN
Inventors:
SUN, Qun; US
Agent:
IGNATENKO, Vasily A.; US
LAVOIE, Teresa A.; US
Priority Data:
62/492,71401.05.2017US
Title (EN) FORMULATIONS AND COMPOSITIONS OF DOCETAXEL
(FR) FORMULATIONS ET COMPOSITIONS DE DOCÉTAXEL
Abstract:
(EN) This document relates to a composition comprising docetaxel, proteins comprising a human serum albumin, and sodium caprylate, wherein the docetaxel and the human serum albumin in the composition have a ratio by weight from about 1:70 to about 1:300, and wherein the composition does not contain sodium N-acetyltryptophanate. This document also relates to a composition consisting essentially of docetaxel, proteins comprising a human serum albumin, and sodium caprylate, wherein the docetaxel and the human serum albumin in the composition have a ratio by weight from about 1:70 to about 1:300, and wherein the composition does not contain sodium N-acetyltryptophanate. This document also relates to a composition comprising docetaxel, proteins comprising a human serum albumin, and sodium N-acetyltryptophanate, wherein the docetaxel and the human serum albumin in the composition have a ratio by weight from about 1:80 to less than 1:150.
(FR) Ce document concerne une composition comprenant du docétaxel, des protéines comprenant une albumine sérique humaine, et du caprylate de sodium, le docétaxel et l'albumine sérique humaine dans la composition ayant un rapport en poids d'environ 1:70 à environ 1:300, et la composition ne contenant pas de N-acétyltryptophanate de sodium. Ce document concerne également une composition constituée essentiellement de docétaxel, des protéines comprenant une albumine sérique humaine, et du caprylate de sodium, le docétaxel et l'albumine sérique humaine dans la composition ayant un rapport en poids d'environ 1:70 à environ 1:300, et la composition ne contenant pas de N-acétyltryptophanate de sodium. Ce document concerne également une composition comprenant du docétaxel, des protéines comprenant une albumine sérique humaine et du N-acétyltryptophanate de sodium, le docétaxel et la l'albumine sérique humaine présents dans la composition ayant un rapport en poids compris entre environ 1:80 et environ 1:150.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)